#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal mesothelioma malignant Pulmonary sarcoidosis Vascular calcification Cutaneous T-cell lymphoma stage I Barth syndrome Follicular lymphoma stage III Retinopathy proliferative Liposarcoma recurrent Bronchopulmonary dysplasia Eosinophilic granulomatosis with polyangiitis Neuroendocrine carcinoma metastatic Congenital nephrogenic diabetes insipidus Mucous membrane pemphigoid Congenital disorder of glycosylation Cushing's syndrome More trials…

    Learn about Rare Diseases

    Sarcoidosis – Diagnostics Progressive supranuclear palsy – Basic Information Ocular melanoma – Trials in Disease Hepatoblastoma – Life with Disease CADASIL Haemophilia – Life with Disease Hereditary motor and sensory neuropathy – Basic Information Factor IX deficiency Ehlers-Danlos syndrome – Treatment Thrombotic thrombocytopenic purpura – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Venlafaxine Hydrochloride Quinapril Hydrochloride Remdesivir Siponimod Arachis Hypogaea (762) Diltiazem Vutrisiran Sargramostim Adrc Imipenem Treosulfan Lisocabtagene Maraleucel Alclometasone Dipropionate Flecainide Acetate Glucose, Anhydrous Vinorelbine Tartrate Piritramide Etavopivat ZOREVUNERSEN SODIUM Zibotentan More therapies…

    Learn about Your Condition

    Antithrombin III deficiency Prostatitis Escherichia coli Rheumatoid arthritis Post-traumatic stress disorder Systemic sclerosis pulmonary Hyperkalaemia Bladder cancer recurrent Guttate psoriasis Nodal osteoarthritis Cutaneous lupus erythematosus Circulatory collapse Carcinoid tumour pulmonary Rectal cancer stage II Colon cancer metastatic Alcohol abuse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteogenesis imperfecta

  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Romosozumab
    Austria Belgium Germany Hungary Italy Slovakia +1

  • Study on Losartan and Hydrochlorothiazide for Osteogenesis Imperfecta in Patients Aged 16 and Above

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Losartan Potassium
    • Hydrochlorothiazide
    Italy

  • Phase 2 Study of AGA2115 in Adults with Osteogenesis Imperfecta (COL1A1/COL1A2 Variants) Evaluating Bone Density

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Denmark France The Netherlands

  • Study on Treating Osteogenesis Imperfecta in Patients Using Teriparatide and Zoledronic Acid

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • ALENDRONATE SODIUM TRIHYDRATE
    • Clodronate Disodium
    • IBANDRONIC ACID
    Denmark France Ireland The Netherlands

  • Study on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Allogeneic Fetal Mesenchymal Stem Cells
    The Netherlands Sweden

  • Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

    Not recruiting

    4 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Setrusumab
    France Germany Italy The Netherlands Poland Portugal
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!